Clinical trials
Phase 1/2 Neoplasm Metastasis trials in Poland
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2012 | 2 |
| 2016 | 2 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 5 |
| Recruiting | 4 |
| Completed | 3 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Merck Sharp & Dohme LLC | 2 |
| Ascendis Pharma Oncology Division A/S | 1 |
| Clovis Oncology, Inc. | 1 |
| CureVac | 1 |
| Eikon Therapeutics | 1 |
| Esperas Pharma Inc. | 1 |
| Kymab Limited | 1 |
| Merck KGaA, Darmstadt, Germany | 1 |
| ModernaTX, Inc. | 1 |
| Nektar Therapeutics | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasm Metastasis | 13 |
| Recurrence | 6 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| Neoplasms | 3 |
| Triple Negative Breast Neoplasms | 3 |
| Carcinoma, Renal Cell | 2 |
| Colorectal Neoplasms | 2 |
| Endometrial Neoplasms | 2 |
| Melanoma | 2 |
| Pancreatic Neoplasms | 2 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.